Second malignant neoplasms among long-term survivors of ovarian cancer

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1564-1570

  Travis, Lois B ^a   Curtis, Rochelle E ^a   Boice Jr , John D ^a   Platz, Charles E ^b   Hankey, Benjamin F ^a   Fraumeni Jr , Joseph F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; HUMAN; HUMAN TISSUE; LEUKEMIA; MELANOMA; OVARY CANCER; PANCREAS CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SURVIVAL TIME;

ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LEUKEMIA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; RISK; SURVIVORS; URINARY BLADDER NEOPLASMS;

EID: 0029911701     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Wingo, P. A., Tong, T , and Bolden, S. Cancer statistics, 1995 CA Cancer J. Clin., 45: 8-30, 1995.
2. Miller, B. A , Ries, L. A. G., Hankey, B. F., Kosary, C. L., Harras, A., Devesa, S. S., and Edwards, B. K. (eds) SEER, Cancer Statistics Review: 1973-1990, NIH Pub. 93-2789. Bethesda, MD: National Cancer Institute, 1993.
3. Kaldor, J. M., Day, N. E , Band, P., Choi, N. W., Clarke, E. A., Coleman, M. P., Hakama, M., Koch, M , Langmark, F., Neal, F. E., Pettersson, F., Pompe-Kirn, V., Prior, P., and Storm, H. H. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int. J. Cancer, 39: 571-585, 1987
4. Curtis, R. E., Hoover, R. N., Kleinerman, R. A., and Harvey, E B. Second cancer following cancer of the female genital system in Connecticut, 1935-1982. NCI Monogr , 68: 113-137, 1985.
5. Prior, P., and Pope, D. J. Subsequent primary cancers in relation to treatment of ovarian cancer Br. J. Cancer, 59: 453-459, 1989.
6. Shah, S., Evans, D G., Blair, V , Burnell, L. D., and Birch, J. M. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies within a cancer registry. Cancer (Phila.), 72: 819-827, 1993.
7. Greene, M. H., Harris, E. L., Gershenson, D. M., Malkasian, G. D., Jr., Melton, L. J., III, Dembo, A. J., Bennett, J. M., Moloney, W. C., and Boice, J. D., Jr Melphalan may be a more potent leukemogen than cyclophosphamide. Ann. Intern. Med , 105. 360-367, 1986.
8. Kaldor, J M., Day, N. E. Pettersson, F., Clark, E. A., Pedersen, D., Mehnert, W., Bell, J., Host, H., Prior, P., Karjalainen, S., Neal, F., Koch, M., Band, P., Choi, W., Pompe Kim, V., Arslan, A., Zaren, B., Belch, A R , Storm, H., Kittelmann, B., Fraser, P., and Stovall, M. Leukemia following chemotherapy for ovarian cancer. N. Engl. J. Med., 322: 1-6, 1990.
9. Cannistra, S. A. Cancer of the ovary. N. Engl J. Med., 329: 1550-1559, 1993.
10. Bagley, C M., Jr., Young, R. C., Canellos, G. P., and DeVita, V. T. Treatment of ovarian carcinoma: possibilities for progress. N. Engl J. Med., 287: 856-862, 1972.
11. Horowitz, C , and Brady, L W Carcinoma of the ovary. In: C. A. Perez and L. W. Brady (eds.), Principles and Practice of Radiation Oncology, pp 988-1015, Philadelphia, PA: J. B. Lippincott Co., 1987.
12. Pezner, R. D , Stevens, K. R., Jr , Tong, D., and Allen, C V. Limited epithelial carcinoma of the ovary treated with curative intent by the intraperitoneal installation of radiocolloids. Cancer (Phila.), 42: 2563-2571, 1978.
13. WHO. International Classification of Diseases for Oncology, Ed. 2 Geneva, Switzerland: WHO, 1990.
14. Percy, C., Young, J L , Jr , Muir, C., Ries, L., Hankey, B. F., Sobin, L. H., and Berg, J. W. Cancer. Introduction. Cancer (Phila.), 75: 140-146, 1995.
15. Platz, C. E , and Benda, J. A. Female genital tract cancer. Cancer (Phila.), 75: 270-294, 1995.
16. Breslow, N E., Lubin, J. H., Marek, P., and Langholz, P. Multiplicative models and cohort analysis. J Am. Stat. Assoc., 78: 1-12, 1983.
17. Haas, J F., Kittelmann, B., Mehnert, W. H., Staneczek, W., Mohner, M., Kaldor, J. M., and Day, N E Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide Br. J. Cancer, 55: 213-218, 1987.
18. Greene, M. H , Boice, J D , Jr., Greer, B E , Blessing, J. A., and Dembo, A. J Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer, a study of five randomized clinical trials, N. Engl J. Med., 307: 1416-1421, 1982
19. Curtis, R. E , Boice, J. D., Jr., Stovall, M., Bernstein, L., Greenberg, R S , Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., and Hoover, R. N. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N. Engl. J. Med., 326, 1745-1751, 1992
20. Greene, M H. Is cisplatin a human carcinogen? J. Natl. Cancer Inst., 84. 306-312, 1992
21. Cheruku, R., Hussain, M., Tyrkus, M , and Edelstein, M. Myelodysplastic syndrome after cisplatin therapy. Cancer (Phila.), 72: 213-218, 1993.
22. Hunger, S. P., Sklar, J., and Link, M. P. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J. Clin Oncol , 10. 156-163, 1992.
23. Auxenfants, E., Morel, P., Lai, J L , Sartiaux, C., Detourmignies, L , Bauters, F., and Fenaux, P Secondary acute lymphoblastic leukemia with t(4,11): report on two cases and review of the literature. Ann. Hematol., 65: 143-146, 1992
24. Pedersen-Bjergaard, J , and Rowley, J D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood. 83: 2780-2786, 1994.
25. Archimbaud, E., Charrin, C., Guyotat, D., Magaud, J. P., Gentilhomme, O , and Fiere, D. Acute leukaemia with t(4;11) in patients previously exposed to carcinogens. Br. J. Haematol., 69. 467-470, 1988.
26. Kapelushnik, J., Dube, I., Wilson, P., and Greenberg, M. Acute lymphoblastic leukemia with t(4,11) translocation after osteogenic sarcoma Cancer (Phila.), 67: 2887-2889, 1991
27. Chen, S J., Chen, Z., Derré, J., Le Coniat, M , Valensi, F., Sigaux, F , and Berger, R. Are most secondary acute lymphoblastic leukemias mixed acute leukemias? Nouv. Res. Fr. Hematol., 31. 17-22, 1989.
28. Palau, F , Prieto, F., Badia, L., Beneyto, M , Sempere, A., and Borrego, D. Cytogenetic evidence of involvement of an early progenitor myeloid cell in 4,11 translocation-associated acute leukemia Cancer Genet. Cytogenet , 51: 79-84, 1991.
29. Boice, J. D., Jr., Blettner, M., Kleinerman, R. A., Engholm, G., Stovall, M., Lisco, H., Austin, D. F., Bosch, A., Harlan, L , Krementz, E. T., Latourette, H. B , Merrill, J A., Peter, L. J., Schulz, M. D , Wactawski, J , Storm, H. H., Bjorkholm, E., Pettersson, F., Bell, C M. J., Coleman, M. P., Fraser, P., Neal, F. E , Prior, P., Choi, N. W., Hislop, T. G., Koch, M., Kreiger, N., Robb, D , Robson, D , Thomson, D H , Lochmuller, H., von Fournier, D., Frischkorn, R., Kjorstad, K. E., Rimpela, A., Pejovic, M., Kirn, V. P., Stankusova, H., Pisani, P , Sigurdsson, K., Hutchison, G. B., and MacMahon, B Radiation dose and breast cancer risk in patients treated for cancer of the cervix. Int. J. Cancer, 44: 7-16, 1989.
30. MacMahon, B., Cole, P., and Brown, J Etiology of human breast cancer a review. J. Natl Cancer Inst , 50. 21-42, 1973.
31. Reimer, R. R , Hoover, R., Fraument, J. F , Jr., and Young, R. C. Second primary neoplasms following ovarian cancer. J. Natl. Cancer Inst. 61: 1195-1197, 1978.
32. Schottenfeld, D., and Berg, J. Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J. Natl Cancer Inst., 46. 161-170, 1971
33. Fraumeni, J. F., Jr , Grundy, G W , Creagan, E T , and Everson, R. B. Six families prone to ovarian cancer. Cancer (Phila), 36: 364-369, 1975.
34. Bewtra, C., Watson, P , Conway, T., Read-Hippee, C., and Lynch, H T. Hereditary ovarian cancer, a clinicopathological study. Int. J. Gynecol. Pathol., 11: 180-187, 1992
35. Szamborski, J., Czerwinski, W., Gadomska, H., Kowalski, M., and Wacker-Pujdak, B Case control study of high-risk factors in ovarian carcinomas Gynecol. Oncol., 11: 8-16, 1981
36. Schildkraut, J. M., and Thompson, W. D. Relationship of epithelial ovarian cancer to other malignancies within families. Genet. Epidemiol., 5 355-367, 1988
37. Schiffman, M , Hartge, P., Hoover, R N , McGowan, L., Lesher, L , and Norris, H. J Letter to the editor. Gynecol. Oncol., 33: 129-132, 1989.
38. Amos, C. L., Shaw, G. L , Tucker, M. A., and Hartge, P Age at onset for familial epithelial ovarian cancer. JAMA, 268: 1896-1899, 1992.
39. Committee on the Biologic Effects of Ionizing Radiation (BEIR V). National Research Council. Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academy Press, 1990.
40. Boice, J. D., Jr., Engholm, G., Kleinerman, R. A., Blettner, M , Stovall, M., Lisco, H., Moloney, W. C , Austin, D. F., Bosch, A., Cookfair, D. L., Krementz, E T , Latourette, H. B., Merrill, J. A., Peters, L. J , Schulz, M. D., Storm, H. H., Bjorkholm, E., Pettersson, F., Bell, C. M J., Coleman, M P , Fraser, P., Neal, F. E , Prior, P , Choi, N. W., Hislop, T. G., Koch, M , Kreiger, N , Robb, D., Robson, D., Thomson, D. H., Lochmuller, H , von Fournier, D , Frischkorn, R., Kjorstad, K E , Rimpela, A., Pejovic, M. H., Kim, V. P , Stankusova, H., Berrino, F., Sigurdsson, K., Hutchison, G. B., and MacMahon, B. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res., 116: 3-55, 1988.
41. McMichael, A. J , and Potter J. D. Reproduction, endogenous and exogeneous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst , 65: 1201-1207, 1980
42. Willett, W C , and MacMahon, B. Diet and cancer - an overview. N. Engl. J. Med., 310: 697-703, 1984.
43. Lynch, H. T., Lanspa, S., Smyrk, T., Boman, B., Watson, P., and Lynch, J. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, part I. Cancer Genet. Cytogenet, 153: 143-160. 1991.
44. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell. 77: 167, 1994] Cell, 75: 1027-1038, 1993.
45. Young, R. H., Gilks, C. B , and Scully, R. E. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A cilnicopathological analysis of 22 cases supporting an origin in the appendix. Am. J. Surg. Pathol., 15: 415-429, 1991
46. Sumithran, E., and Susil, B. J. Concomitant mucinous tumors of appendix and ovary. Result of a neoplastic field change? Cancer (Phila.), 70: 2980-2983, 1992.
47. Seidman, J. D., Elsayed, A. M., Sobin, L. H., and Tavassoli, F. A. Association of mucinous tumors of the ovary and appendix A clinocopathologic study of 25 cases Am. J. Surg. Pathol , 17: 22-34, 1993
48. Prayson, R. A., Hart, W. R., and Petras, R E. Pseudomyxoma peritonei A clinico-pathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am. J. Surg. Pathol., 18: 591-603, 1994.
49. Griem, M. L., Kleinerman, R. A., Boice, J. D., Jr., Stovall, M., Shefner, D., and Lubin, J. H Cancer following radiotherapy for peptic ulcer. J. Natl. Cancer Inst. 86: 842-849, 1994.
50. Kaldor, J M , Day, N. E., Kittelmann, B., Pettersson, F., Langmark, F., Pedersen, D., Prior, P., Neal, F., Karjalainen S., Bell, J., Choi, W., Koch, M., Band, P., Pompe-Kirn, V., Garton, C., Staneczek, W , Zaren, B., Stovall, M., and Boffetta, P. Bladder rumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int. J. Cancer, 63: 1-6, 1995
51. Travis, L. B., Curtis, R. E , Glimelius, B., Holowaty, E. J., Van Leeuwen, F. E., Lynch, C. F., Hagenbeek, A., Stovall, M., Banks, P. M., Adami, H-O., Gospodarowicz, M. K., Wacholder, S., Inskip, P. D., Tucker, M. A., and Boice, J D , Jr. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J. Natl. Cancer Inst., 87. 524-530, 1995.
52. Young, L H., Egan, K M., Walsh, S. M., and Gragoudas, E. S. Familial uveal melanoma. Am. J Ophthalmol., 117: 516-520, 1994.
53. Hartge, P., Tucker, M. A., Shields, J A , Augsburger, J., Hoover, R. N., and Fraumeni, J. F., Jr Case-control study of female hormones and eye melanoma Cancer Res , 4: 4622-4625, 1989
54. Wooster, R., Neuhausen, S L , Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T , Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feurteun, J , Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R , Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A J., Skolnick, M. H., Easton, D F., Goldgar, D E., and Stratton, M. R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 205. 2088-2090, 1994.
55. Goldgar, D. E., Neuhausen, S. L., Steele, L , Field, P., Ward, J. H., Tran, T., Nguyen, K , Stratton, M. R., and Easton, D. F A 45-year follow-up of kindred 107 and the search for BRCA2. NCI Monogr., 17: 15-19, 1995
56. Mullaney, J., Mooney, D , O'Connor, M., and McDonald, G S. Bilateral ovarian carcinoma with bilateral uveal melanoma Br. J Ophthalmol., 68: 261-267, 1984.
57. Cramer, S F., Roth, L M., Ulbright, T M., Mazur, M. T., Nunez, C A , Gersell, D. J., Mills, S E , and Kraus, F. T. Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology. Arch. Pathol. Lab. Med., 111: 819-829, 1987.
58. Monson R. R. The interpretation of epidemiologic data In: Occupational Epidemiology, pp. 93-103 Boca Raton, FL: CRC Press, Inc , 1980.
59. NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer: screening, treatment, and follow-up JAMA, 273: 491-497, 1995.